Found: 5
Select item for more details and to access through your institution.
Sarcopenia: recent advances for detection, progression, and metabolic alterations along with therapeutic targets.
- Published in:
- Canadian Journal of Physiology & Pharmacology, 2024, v. 102, n. 12, p. 697, doi. 10.1139/cjpp-2024-0201
- By:
- Publication type:
- Article
Cardiovascular adverse events associated with norepinephrine–dopamine reuptake inhibitors: a pharmacovigilance study of the FDA Adverse Event Reporting System.
- Published in:
- Canadian Journal of Physiology & Pharmacology, 2024, v. 102, n. 12, p. 709, doi. 10.1139/cjpp-2024-0128
- By:
- Publication type:
- Article
Cardiovascular adverse events associated with triptans for treatment of migraine: a pharmacovigilance study of the FDA adverse event reporting system (FAERS).
- Published in:
- Canadian Journal of Physiology & Pharmacology, 2024, v. 102, n. 12, p. 720, doi. 10.1139/cjpp-2024-0117
- By:
- Publication type:
- Article
Lysophosphatidic acid metabolism and signaling in heart disease.
- Published in:
- Canadian Journal of Physiology & Pharmacology, 2024, v. 102, n. 12, p. 685, doi. 10.1139/cjpp-2024-0077
- By:
- Publication type:
- Article
Nebivolol prevents redox imbalance and attenuates bladder dysfunction induced by cyclophosphamide in mice.
- Published in:
- Canadian Journal of Physiology & Pharmacology, 2024, v. 102, n. 12, p. 729, doi. 10.1139/cjpp-2024-0064
- By:
- Publication type:
- Article